BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Cellectar Biosciences Inc.

NASDAQ: CLRB    
Share price (6/16/25): $0.38    
Market cap (6/16/25): $17.6 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Earnings Revised 05/13/25 Cellectar Biosciences, Inc., Q1 2025 Earnings Call, May 13, 2025 05/13/25 Earnings Revised 03/14/25 Cellectar Biosciences, Inc., 2024 Earnings Call, Mar 13, 2025 03/13/25 Other Revised 01/14/25 Cellectar Biosciences, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 11:30 AM 01/14/25
CY 2024
Earnings Revised 11/18/24 Cellectar Biosciences, Inc., Q3 2024 Earnings Call, Nov 18, 2024 11/18/24 Earnings Revised 09/05/24 Cellectar Biosciences, Inc., Q2 2024 Earnings Call, Aug 13, 2024 08/13/24 Other Revised 07/24/24 Cellectar Biosciences, Inc. - Special Call 07/24/24 Earnings Revised 05/15/24 Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 05/14/24 Earnings Revised 03/27/24 Cellectar Biosciences, Inc., 2023 Earnings Call, Mar 27, 2024 03/27/24 Other Revised 01/19/24 Cellectar Biosciences, Inc. - Special Call 01/19/24 Other Revised 01/08/24 Cellectar Biosciences, Inc. - Special Call 01/08/24
CY 2023
Earnings Revised 12/12/23 Cellectar Biosciences, Inc., Q3 2023 Earnings Call, Nov 02, 2023 11/02/23
CY 2021
Other Revised 06/04/21 Cellectar Biosciences, Inc. - Special Call 06/04/21 Other Revised 03/16/21 Cellectar Biosciences, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 08:00 AM 03/16/21 Other Revised 02/15/21 Cellectar Biosciences, Inc. Presents at BIO CEO & Investor Digital Conference 2021, Feb-16-2021 02/15/21